(AVIR Green Hills Biotechnology AG) deltaFLU –innovative vaccines for intranasal spray delivery or oral administration more 
(Apeptico) APEPTICO Announces Successful Completion of Phase I Trial with AP301 in Oedematous Respiratory Failure more 
(Intercell) Intercell announces new management structure more 
(Eucodis) EUCODIS Bioscience and evocatal enter into alliance more 
(Intercell) Staph Bakali new Chief Business Officer more 
(Intercell) Intercell acquires antibody technology platform to further exploit its capabilities to combat infectious diseases more 
(Apeptico) APEPTICO granted Orphan Drug Designation by FDA for development compound AP301 more 
DEUTSCH

